STRW
Strawberry Fields REIT LLC
REIT - Healthcare Facilities
Market Cap$170M
5Y Perf.+25.7%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
STRW vs GMRE
Revenue, margins, valuation, and 5-year total return — side by side.
GMRE
Global Medical REIT Inc.
REIT - Healthcare Facilities
Market Cap$94M
5Y Perf.-18.7%
STRW vs GMRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | STRW | GMRE |
|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $170M | $94M |
| Revenue (TTM) | $145M | $148M |
| Net Income (TTM) | $7M | $2M |
| Gross Margin | 81.4% | 68.8% |
| Operating Margin | 54.3% | 24.9% |
| Forward P/E | 19.4x | 595.7x |
| Total Debt | $672M | $654M |
| Cash & Equiv. | $48M | $7M |
STRW vs GMRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
STRW
GMRE
| Stock | Sep 22 | May 26 | Return |
|---|---|---|---|
| Strawberry Fields R… (STRW) | 100 | 125.7 | +25.7% |
| Global Medical REIT… (GMRE) | 100 | 81.3 | -18.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STRW vs GMRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: STRW leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Global Medical REIT Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
STRW
Strawberry Fields REIT LLC
The Real Estate Income Play
STRW carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 17.3%, EPS growth 46.2%, 3Y rev CAGR 10.4%
- 17.3% FFO/revenue growth vs GMRE's -1.8%
- Lower P/E (19.4x vs 595.7x)
Best for: growth exposure
GMRE
Global Medical REIT Inc.
The Real Estate Income Play
GMRE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 308.1% 10Y total return vs STRW's 47.8%
- Lower volatility, beta 0.48, current ratio 0.03x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | STRW | 17.3% FFO/revenue growth vs GMRE's -1.8% |
| Value | STRW | Lower P/E (19.4x vs 595.7x) |
| Quality / Margins | STRW | 4.8% margin vs GMRE's 1.7% |
| Stability / Safety | GMRE | Beta 0.48 vs STRW's 0.69, lower leverage |
| Dividends | GMRE | 63.5% yield, 5-year raise streak, vs STRW's 4.4% |
| Momentum (1Y) | STRW | +29.7% vs GMRE's +0.1% |
| Efficiency (ROA) | STRW | 0.8% ROA vs GMRE's 0.2%, ROIC 7.2% vs 2.0% |
STRW vs GMRE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLSTRWLAGGINGGMRE
GMREGlobal Medical REIT I…
1leads
STRWStrawberry Fields REI…
4leads
6 Total Categories
CATEGORYLEADERvs GMREMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
STRW6/6
Valuation MetricsMultiples, price ratios, and targets
STRW3/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
STRW7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
STRW4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
GMRE2/2
Income & Cash Flow (Last 12 Months)
STRW leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GMRE and STRW operate at a comparable scale, with $148M and $145M in trailing revenue. Profitability is closely matched — net margins range from 4.8% (STRW) to 1.7% (GMRE). On growth, STRW holds the edge at +34.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | STRWStrawberry Fields… | GMREGlobal Medical RE… |
|---|---|---|
| RevenueTrailing 12 months | $145M | $148M |
| EBITDAEarnings before interest/tax | $123M | $95M |
| Net IncomeAfter-tax profit | $7M | $2M |
| Free Cash FlowCash after capex | $88M | $19M |
| Gross MarginGross profit ÷ Revenue | +81.4% | +68.8% |
| Operating MarginEBIT ÷ Revenue | +54.3% | +24.9% |
| Net MarginNet income ÷ Revenue | +4.8% | +1.7% |
| FCF MarginFCF ÷ Revenue | +60.7% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +34.8% | +18.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.7% | -166.2% |
STRW leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
STRW leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 22.7x trailing earnings, STRW trades at a 80% valuation discount to GMRE's 115.3x P/E. On an enterprise value basis, STRW's 8.3x EV/EBITDA is more attractive than GMRE's 8.3x.
| Metric | STRWStrawberry Fields… | GMREGlobal Medical RE… |
|---|---|---|
| Market CapShares × price | $170M | $94M |
| Enterprise ValueMkt cap + debt − cash | $793M | $741M |
| Trailing P/EPrice ÷ TTM EPS | 22.72x | 115.29x |
| Forward P/EPrice ÷ next-FY EPS est. | 19.44x | 595.67x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 8.31x | 8.35x |
| Price / SalesMarket cap ÷ Revenue | 1.45x | 0.68x |
| Price / BookPrice ÷ Book value/share | 1.10x | 0.17x |
| Price / FCFMarket cap ÷ FCF | 4.81x | — |
STRW leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
STRW leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
STRW delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $0 for GMRE. GMRE carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to STRW's 8.04x. On the Piotroski fundamental quality scale (0–9), STRW scores 7/9 vs GMRE's 4/9, reflecting strong financial health.
| Metric | STRWStrawberry Fields… | GMREGlobal Medical RE… |
|---|---|---|
| ROE (TTM)Return on equity | +11.2% | +0.5% |
| ROA (TTM)Return on assets | +0.8% | +0.2% |
| ROICReturn on invested capital | +7.2% | +2.0% |
| ROCEReturn on capital employed | +9.0% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 8.04x | 1.18x |
| Net DebtTotal debt minus cash | $623M | $647M |
| Cash & Equiv.Liquid assets | $48M | $7M |
| Total DebtShort + long-term debt | $672M | $654M |
| Interest CoverageEBIT ÷ Interest expense | 1.82x | 1.14x |
STRW leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
STRW leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in STRW five years ago would be worth $14,780 today (with dividends reinvested), compared to $7,855 for GMRE. Over the past 12 months, STRW leads with a +29.7% total return vs GMRE's +0.1%. The 3-year compound annual growth rate (CAGR) favors STRW at 27.9% vs GMRE's 1.8% — a key indicator of consistent wealth creation.
| Metric | STRWStrawberry Fields… | GMREGlobal Medical RE… |
|---|---|---|
| YTD ReturnYear-to-date | +1.0% | +6.9% |
| 1-Year ReturnPast 12 months | +29.7% | +0.1% |
| 3-Year ReturnCumulative with dividends | +109.3% | +5.6% |
| 5-Year ReturnCumulative with dividends | +47.8% | -21.4% |
| 10-Year ReturnCumulative with dividends | +47.8% | +308.1% |
| CAGR (3Y)Annualised 3-year return | +27.9% | +1.8% |
STRW leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
Evenly matched — STRW and GMRE each lead in 1 of 2 comparable metrics.
Risk & Volatility
GMRE is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than STRW's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | STRWStrawberry Fields… | GMREGlobal Medical RE… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.69x | 0.48x |
| 52-Week HighHighest price in past year | $14.00 | $39.93 |
| 52-Week LowLowest price in past year | $9.46 | $29.05 |
| % of 52W HighCurrent price vs 52-week peak | +92.5% | +89.5% |
| RSI (14)Momentum oscillator 0–100 | 51.6 | 52.7 |
| Avg Volume (50D)Average daily shares traded | 23K | 130K |
Evenly matched — STRW and GMRE each lead in 1 of 2 comparable metrics.
Analyst Outlook
GMRE leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates STRW as "Buy" and GMRE as "Buy". Consensus price targets imply 18.4% upside for STRW (target: $15) vs 11.9% for GMRE (target: $40). For income investors, GMRE offers the higher dividend yield at 63.51% vs STRW's 4.37%.
| Metric | STRWStrawberry Fields… | GMREGlobal Medical RE… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $15.33 | $40.00 |
| # AnalystsCovering analysts | 2 | 22 |
| Dividend YieldAnnual dividend ÷ price | +4.4% | +63.5% |
| Dividend StreakConsecutive years of raises | 2 | 5 |
| Dividend / ShareAnnual DPS | $0.57 | $22.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | 0.0% |
GMRE leads this category, winning 2 of 2 comparable metrics.
Key Takeaway
STRW leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). GMRE leads in 1 (Analyst Outlook). 1 tied.
Best OverallStrawberry Fields REIT LLC (STRW)Leads 4 of 6 categories
Loading custom metrics...
STRW vs GMRE: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is STRW or GMRE a better buy right now?
For growth investors, Strawberry Fields REIT LLC (STRW) is the stronger pick with 17.
3% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Strawberry Fields REIT LLC (STRW) offers the better valuation at 22. 7x trailing P/E (19. 4x forward), making it the more compelling value choice. Analysts rate Strawberry Fields REIT LLC (STRW) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — STRW or GMRE?
On trailing P/E, Strawberry Fields REIT LLC (STRW) is the cheapest at 22.
7x versus Global Medical REIT Inc. at 115. 3x. On forward P/E, Strawberry Fields REIT LLC is actually cheaper at 19. 4x.
03Which is the better long-term investment — STRW or GMRE?
Over the past 5 years, Strawberry Fields REIT LLC (STRW) delivered a total return of +47.
8%, compared to -21. 4% for Global Medical REIT Inc. (GMRE). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus STRW's +47. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — STRW or GMRE?
By beta (market sensitivity over 5 years), Global Medical REIT Inc.
(GMRE) is the lower-risk stock at 0. 48β versus Strawberry Fields REIT LLC's 0. 69β — meaning STRW is approximately 44% more volatile than GMRE relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 8% for Strawberry Fields REIT LLC — giving it more financial flexibility in a downturn.
05Which is growing faster — STRW or GMRE?
By revenue growth (latest reported year), Strawberry Fields REIT LLC (STRW) is pulling ahead at 17.
3% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Strawberry Fields REIT LLC grew EPS 46. 2% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, STRW leads at 10. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — STRW or GMRE?
Global Medical REIT Inc.
(GMRE) is the more profitable company, earning 4. 8% net margin versus 3. 5% for Strawberry Fields REIT LLC — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STRW leads at 52. 4% versus 23. 6% for GMRE. At the gross margin level — before operating expenses — STRW leads at 87. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is STRW or GMRE more undervalued right now?
On forward earnings alone, Strawberry Fields REIT LLC (STRW) trades at 19.
4x forward P/E versus 595. 7x for Global Medical REIT Inc. — 576. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for STRW: 18. 4% to $15. 33.
08Which pays a better dividend — STRW or GMRE?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 4. 4% for Strawberry Fields REIT LLC (STRW).
09Is STRW or GMRE better for a retirement portfolio?
For long-horizon retirement investors, Global Medical REIT Inc.
(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, STRW: +47. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between STRW and GMRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: STRW is a small-cap high-growth stock; GMRE is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(STRW: 34.8% · GMRE: 18.7%)P/E Ratio<
x
(STRW: 22.7x · GMRE: 115.3x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.